5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: A real-life study

Elide Anna Pastorello, Laura Losappio, Stefania Milani, Giuseppina Manzotti, Valentina Fanelli, Valerio Pravettoni, Fabio Agostinis, Alberto Flores D'Arcais, Ilaria Dell'Albani, Paola Puccinelli, Cristoforo Incorvaia, Franco Frati

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to drug treatment. It has been reported that grass pollen subcutaneous immunotherapy is effective in drug-resistant patients. In a real-life study, we evaluated the efficacy of 5-grass pollen tablets in patients with grass pollen-induced allergic rhinitis not responsive to drug therapy. Methods: We carried out this multicenter observational study in adults and adolescents with grass-induced allergic rhinitis not responsive to drug therapy who were treated for a year with 5-grass pollen tablets. Clinical data collected before and after sublingual immunotherapy (SLIT) included Allergic Rhinitis and its Impact on Asthma (ARIA) classification of allergic rhinitis, response to therapy, and patient satisfaction. Results: Forty-seven patients entered the study. By ARIA classification, three patients had moderate to severe intermittent allergic rhinitis, ten had mild persistent allergic rhinitis, and 34 had moderate to severe persistent allergic rhinitis. There were no cases of mild intermittent allergic rhinitis before SLIT. After SLIT, 33 patients had mild intermittent allergic rhinitis, none had moderate to severe intermittent allergic rhinitis, seven had mild persistent allergic rhinitis, and seven had moderate to severe persistent allergic rhinitis. The mean medication score decreased from 4.2±1.3 before to 2.4±2.0 after SLIT (P

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalJournal of Asthma and Allergy
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Seasonal Allergic Rhinitis
Pollen
Poaceae
Tablets
Pharmaceutical Preparations
Sublingual Immunotherapy
Allergic Rhinitis
Asthma
Drug Therapy
Patient Satisfaction
Immunotherapy
Multicenter Studies
Observational Studies

Keywords

  • Allergen immunotherapy
  • Drug resistance
  • Effectiveness
  • Grass pollen
  • Patient satisfaction
  • Rhinitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs : A real-life study. / Pastorello, Elide Anna; Losappio, Laura; Milani, Stefania; Manzotti, Giuseppina; Fanelli, Valentina; Pravettoni, Valerio; Agostinis, Fabio; D'Arcais, Alberto Flores; Dell'Albani, Ilaria; Puccinelli, Paola; Incorvaia, Cristoforo; Frati, Franco.

In: Journal of Asthma and Allergy, No. 6, 2013, p. 127-133.

Research output: Contribution to journalArticle

Pastorello, EA, Losappio, L, Milani, S, Manzotti, G, Fanelli, V, Pravettoni, V, Agostinis, F, D'Arcais, AF, Dell'Albani, I, Puccinelli, P, Incorvaia, C & Frati, F 2013, '5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: A real-life study', Journal of Asthma and Allergy, no. 6, pp. 127-133. https://doi.org/10.2147/JAA.S53801
Pastorello, Elide Anna ; Losappio, Laura ; Milani, Stefania ; Manzotti, Giuseppina ; Fanelli, Valentina ; Pravettoni, Valerio ; Agostinis, Fabio ; D'Arcais, Alberto Flores ; Dell'Albani, Ilaria ; Puccinelli, Paola ; Incorvaia, Cristoforo ; Frati, Franco. / 5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs : A real-life study. In: Journal of Asthma and Allergy. 2013 ; No. 6. pp. 127-133.
@article{46041eaba38447f1a975576617f86676,
title = "5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: A real-life study",
abstract = "Background: An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to drug treatment. It has been reported that grass pollen subcutaneous immunotherapy is effective in drug-resistant patients. In a real-life study, we evaluated the efficacy of 5-grass pollen tablets in patients with grass pollen-induced allergic rhinitis not responsive to drug therapy. Methods: We carried out this multicenter observational study in adults and adolescents with grass-induced allergic rhinitis not responsive to drug therapy who were treated for a year with 5-grass pollen tablets. Clinical data collected before and after sublingual immunotherapy (SLIT) included Allergic Rhinitis and its Impact on Asthma (ARIA) classification of allergic rhinitis, response to therapy, and patient satisfaction. Results: Forty-seven patients entered the study. By ARIA classification, three patients had moderate to severe intermittent allergic rhinitis, ten had mild persistent allergic rhinitis, and 34 had moderate to severe persistent allergic rhinitis. There were no cases of mild intermittent allergic rhinitis before SLIT. After SLIT, 33 patients had mild intermittent allergic rhinitis, none had moderate to severe intermittent allergic rhinitis, seven had mild persistent allergic rhinitis, and seven had moderate to severe persistent allergic rhinitis. The mean medication score decreased from 4.2±1.3 before to 2.4±2.0 after SLIT (P",
keywords = "Allergen immunotherapy, Drug resistance, Effectiveness, Grass pollen, Patient satisfaction, Rhinitis",
author = "Pastorello, {Elide Anna} and Laura Losappio and Stefania Milani and Giuseppina Manzotti and Valentina Fanelli and Valerio Pravettoni and Fabio Agostinis and D'Arcais, {Alberto Flores} and Ilaria Dell'Albani and Paola Puccinelli and Cristoforo Incorvaia and Franco Frati",
year = "2013",
doi = "10.2147/JAA.S53801",
language = "English",
pages = "127--133",
journal = "Journal of Asthma and Allergy",
issn = "1178-6965",
publisher = "Dove Medical Press Ltd.",
number = "6",

}

TY - JOUR

T1 - 5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs

T2 - A real-life study

AU - Pastorello, Elide Anna

AU - Losappio, Laura

AU - Milani, Stefania

AU - Manzotti, Giuseppina

AU - Fanelli, Valentina

AU - Pravettoni, Valerio

AU - Agostinis, Fabio

AU - D'Arcais, Alberto Flores

AU - Dell'Albani, Ilaria

AU - Puccinelli, Paola

AU - Incorvaia, Cristoforo

AU - Frati, Franco

PY - 2013

Y1 - 2013

N2 - Background: An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to drug treatment. It has been reported that grass pollen subcutaneous immunotherapy is effective in drug-resistant patients. In a real-life study, we evaluated the efficacy of 5-grass pollen tablets in patients with grass pollen-induced allergic rhinitis not responsive to drug therapy. Methods: We carried out this multicenter observational study in adults and adolescents with grass-induced allergic rhinitis not responsive to drug therapy who were treated for a year with 5-grass pollen tablets. Clinical data collected before and after sublingual immunotherapy (SLIT) included Allergic Rhinitis and its Impact on Asthma (ARIA) classification of allergic rhinitis, response to therapy, and patient satisfaction. Results: Forty-seven patients entered the study. By ARIA classification, three patients had moderate to severe intermittent allergic rhinitis, ten had mild persistent allergic rhinitis, and 34 had moderate to severe persistent allergic rhinitis. There were no cases of mild intermittent allergic rhinitis before SLIT. After SLIT, 33 patients had mild intermittent allergic rhinitis, none had moderate to severe intermittent allergic rhinitis, seven had mild persistent allergic rhinitis, and seven had moderate to severe persistent allergic rhinitis. The mean medication score decreased from 4.2±1.3 before to 2.4±2.0 after SLIT (P

AB - Background: An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to drug treatment. It has been reported that grass pollen subcutaneous immunotherapy is effective in drug-resistant patients. In a real-life study, we evaluated the efficacy of 5-grass pollen tablets in patients with grass pollen-induced allergic rhinitis not responsive to drug therapy. Methods: We carried out this multicenter observational study in adults and adolescents with grass-induced allergic rhinitis not responsive to drug therapy who were treated for a year with 5-grass pollen tablets. Clinical data collected before and after sublingual immunotherapy (SLIT) included Allergic Rhinitis and its Impact on Asthma (ARIA) classification of allergic rhinitis, response to therapy, and patient satisfaction. Results: Forty-seven patients entered the study. By ARIA classification, three patients had moderate to severe intermittent allergic rhinitis, ten had mild persistent allergic rhinitis, and 34 had moderate to severe persistent allergic rhinitis. There were no cases of mild intermittent allergic rhinitis before SLIT. After SLIT, 33 patients had mild intermittent allergic rhinitis, none had moderate to severe intermittent allergic rhinitis, seven had mild persistent allergic rhinitis, and seven had moderate to severe persistent allergic rhinitis. The mean medication score decreased from 4.2±1.3 before to 2.4±2.0 after SLIT (P

KW - Allergen immunotherapy

KW - Drug resistance

KW - Effectiveness

KW - Grass pollen

KW - Patient satisfaction

KW - Rhinitis

UR - http://www.scopus.com/inward/record.url?scp=84889247826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889247826&partnerID=8YFLogxK

U2 - 10.2147/JAA.S53801

DO - 10.2147/JAA.S53801

M3 - Article

AN - SCOPUS:84889247826

SP - 127

EP - 133

JO - Journal of Asthma and Allergy

JF - Journal of Asthma and Allergy

SN - 1178-6965

IS - 6

ER -